NormOxys, Inc., is a biotechnology company developing a new class of small molecule drugs which are derivatives of polyol phosphates. This platform promises to offer breakthrough treatments for a wide variety of cancers.
Finance: Commercial Banking, Lending, Underwriting
No mentions listed yet.
No one has curated this page yet. Be the first.
Curate